120 related articles for article (PubMed ID: 11273105)
1. Prognostic significance of thyroid antibodies in hyperthyroid patients treated with antithyroid drugs.
Khanna CM; Shanker R; Magdum M; Jain SK; Jaggi CB
J Assoc Physicians India; 1998 Feb; 46(2):176-8. PubMed ID: 11273105
[TBL] [Abstract][Full Text] [Related]
2. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
[TBL] [Abstract][Full Text] [Related]
3. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
5. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of thyroid antibodies in hyperthyroid patients treated with antithyroid drugs.
Joshi SR
J Assoc Physicians India; 1999 Mar; 47(3):351. PubMed ID: 10999142
[No Abstract] [Full Text] [Related]
7. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
[TBL] [Abstract][Full Text] [Related]
8. [Effect of universal salt iodization on the dosage of antithyroid drug].
Dai WX; Lian XL; Lu L; Li SM; Li SH; Li XW
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2142-5. PubMed ID: 14720423
[TBL] [Abstract][Full Text] [Related]
9. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
10. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
11. [Value of suppression test as a guide to prognosis of hyper-thyroidism treated with anti-thyroid drugs (author's transl)].
Foldenauer A; Marquart F
Dtsch Med Wochenschr; 1975 Mar; 100(13):678-9. PubMed ID: 47288
[TBL] [Abstract][Full Text] [Related]
12. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
13. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
14. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
15. PREDICTION OF RELAPSE FROM HYPERTHYROIDISM FOLLOWING ANTITHYROID MEDICATION WITHDRAWAL USING TECHNETIUM THYROID UPTAKE SCANNING.
Nakhjavani M; Abdollahi S; Farzanefar S; Abousaidi M; Esteghamati A; Naseri M; Eftekhari M; Abbasi M
Endocr Pract; 2017 Apr; 23(4):466-470. PubMed ID: 28437154
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
17. Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes.
Martin FI; Deam DR
Med J Aust; 1996 Feb; 164(4):200-3. PubMed ID: 8604186
[TBL] [Abstract][Full Text] [Related]
18. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay.
Massart C; Gibassier J; d'Herbomez M
Clin Chim Acta; 2009 Sep; 407(1-2):62-6. PubMed ID: 19576193
[TBL] [Abstract][Full Text] [Related]
20. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
